Influenza
Adjunct
Black elderberry as Sambucol syrup is positioned for influenza. The original Zakay-Rones 2004 RCT in 60 patients with lab-confirmed influenza A/B showed 4-day symptom duration reduction vs placebo with 15 mL syrup four times daily for 5 days. The Hawkins 2019 meta-analysis included this trial plus 3 more RCTs. Limitations: small samples, single-centre design, potential conflict of interest. 2018 in confirmed influenza in patients with risk factors (age ≥65, pregnancy, immunosuppression, chronic disease) lists oseltamivir within 48 hours of symptom onset first-line; elderberry is in the «complementary, evidence limited» category. In Austria Sambucol was registered in 2024 as an OTC product with «cold and flu» indication. If elderberry was recommended as a substitute for oseltamivir in a high-risk patient, consider seeking a second opinion.
Sources
- J Int Med Res: Randomised study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections (2004)
- Complement Ther Med: Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: meta-analysis of randomised controlled trials (2019)
- IDSA: Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis and institutional outbreak management of seasonal influenza (2018)
- Cochrane: Interventions for treating influenza in adults and children: complementary therapies review (2024)